Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000208334 | SCV000263890 | uncertain significance | Primary dilated cardiomyopathy | 2015-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002517395 | SCV003035277 | uncertain significance | Left ventricular noncompaction 1 | 2023-04-22 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 696 of the DTNA protein (p.Thr696Met). This variant is present in population databases (rs200977103, gnomAD 0.006%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 222594). This variant has not been reported in the literature in individuals affected with DTNA-related conditions. |
Diagnostic Laboratory, |
RCV001528816 | SCV001741210 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001528816 | SCV001929077 | uncertain significance | not provided | no assertion criteria provided | clinical testing |